As of today (2024-04-24), Arcus Biosciences's share price is $15.50. Arcus Biosciences's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $6.12. Hence, Arcus Biosciences's Price to Tangible Book Ratio of today is 2.53.
The historical rank and industry rank for Arcus Biosciences's Price-to-Tangible-Book or its related term are showing as below:
RCUS'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 2.04 Med: 2.98 Max: 3.4
Current: 2.53
During the past 8 years, Arcus Biosciences's highest Price to Tangible Book Ratio was 3.40. The lowest was 2.04. And the median was 2.98.
RCUS's Price-to-Tangible-Book is ranked better than 52.96% of 1218
companies
in the Biotechnology industry
Industry Median: 2.69
vs RCUS: 2.53
A closely related ratio is called PB Ratio. As of today, Arcus Biosciences's share price is $15.50. Arcus Biosciences's Book Value per Sharefor the quarter that ended in Dec. 2023 was $6.12. Hence, Arcus Biosciences's P/B Ratio of today is 2.53.
Arcus Biosciences Price-to-Tangible-Book Historical Data
The historical data trend for Arcus Biosciences's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Arcus Biosciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcus Biosciences Price-to-Tangible-Book Distribution
For the Biotechnology industry and Healthcare sector, Arcus Biosciences's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where Arcus Biosciences's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
Arcus Biosciences Price-to-Tangible-Book Related Terms
Thank you for viewing the detailed overview of Arcus Biosciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.
Arcus Biosciences (Arcus Biosciences) Business Description
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB680, and Zimberelimab. Arcus conducts clinical trials for different types of cancers such as Prostate, Lung, Colorectal, Pancreatic, and others. The company operates through the single segment being the business of developing and commercializing immunotherapies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RCUS has been successfully added to your 